title: Correlation between ebv co-infection and HPV16 genome integrity in Tunisian cervical cancer patients.
abstract: Infection with high risk Human papillomavirus (HR-HPV) is necessary but not sufficient to cause cervical carcinoma. This study explored whether multiple HR-HPV or coinfection with Epstein-Barr virus (EBV) influence the integration status of HPV16 genome. The presence and typing of HPV in a series of 125 cervical specimens were assessed by polymerase chain reaction (PCR) using the specific primers for the HPV L1 region. As for EBV infection, the viral EBNA1 gene was used for its detection through PCR amplification. Disruption of the HPV E2 gene was assessed by amplification of the entire E2 gene with single set of primers, while E2 transcripts were evaluated by a reverse transcription PCR method (RT-PCR). The overall prevalence of HPVDNA was of 81.8% in cervical cancers versus 26.9% in benign lesions. In HPV positive cases, HPV16 and HPV18 were the most prevalent types, followed by HPV types 33, 31. EBV EBNA1 prevalence was statistically more frequent in cervical carcinomas than in benign lesions (29.5%, vs 9.6%; P=0.01). No viral infection was detected in healthy control women. The uninterrupted E2 gene was correlated with the presence of E2 transcripts originating from the HPV episomal forms. It was observed that integration was more common in HPV18 and EBV coinfection. The presence of EBV caused a five-fold [OR= 5; CI= 1.15-21.8; P = 0.04] increase in the risk of HPV16 genome integration in the host genome. This study indicates that EBV infection is acting as a cofactor for induction of cervical cancer by favoring HPVDNA integration.
authors.affiliation: Unit of Immunology Microbiology Environmental and Carcinogenesis (IMEC), Science Faculty of Bizerte, University of Carthage , 7021 Jarzouna, Bizerte , Tunisia.
authors.forename: Saloua
authors.initials: S
authors.lastname: Kahla
authors.forename: Sarra
authors.initials: S
authors.lastname: Oueslati
authors.forename: Mongia
authors.initials: M
authors.lastname: Achour
authors.forename: Lotfi
authors.initials: L
authors.lastname: Kochbati
authors.forename: Mohamed Badis
authors.initials: MB
authors.lastname: Chanoufi
authors.forename: Mongi
authors.initials: M
authors.lastname: Maalej
authors.forename: Ridha
authors.initials: R
authors.lastname: Oueslati
keywords: Cervical cancer; E2 gene; E2 mRNA; Epstein-Barr virus; High risk human papillomaviruses
references.citation: Int J Radiat Oncol Biol Phys. 2010 Nov 15;78(4):1111-20
references.pmid: 20231068
references.citation: J Clin Microbiol. 2002 Mar;40(3):863-7
references.pmid: 11880406
references.citation: Virus Res. 2002 Nov;89(2):213-28
references.pmid: 12445661
references.citation: Clin Cancer Res. 2003 Sep 15;9(11):4145-50
references.pmid: 14519638
references.citation: Cancer Res. 2010 Jul 1;70(13):5316-25
references.pmid: 20530671
references.citation: Virulence. 2011 Jan-Feb;2(1):58-62
references.pmid: 21217204
references.citation: Gynecol Oncol. 2007 Aug;106(2):299-304
references.pmid: 17586029
references.citation: J Biosci. 2008 Mar;33(1):73-80
references.pmid: 18376072
references.citation: Arch Pathol Lab Med. 1999 Nov;123(11):1098-100
references.pmid: 10539915
references.citation: J Biomol Screen. 2010 Oct;15(9):1107-15
references.pmid: 20930215
references.citation: Braz J Microbiol. 2008 Jul;39(3):573-8
references.pmid: 24031268
references.citation: J Natl Cancer Inst. 2010 Oct 6;102(19):1478-88
references.pmid: 20841605
references.citation: Virology. 2009 Feb 20;384(2):375-9
references.pmid: 19064276
references.citation: Cancer Res. 2009 May 1;69(9):3828-32
references.pmid: 19401452
references.citation: Pol J Microbiol. 2004;53(2):95-9
references.pmid: 15478354
references.citation: Int J Clin Exp Pathol. 2009;2(1):48-64
references.pmid: 18830380
references.citation: Braz J Microbiol. 2011 Apr;42(2):786-93
references.pmid: 24031694
references.citation: Infect Agent Cancer. 2011 Jan 17;6(1):1
references.pmid: 21241508
references.citation: Cancer Res. 2008 Jan 1;68(1):307-13
references.pmid: 18172324
references.citation: J Virol. 2005 Nov;79(21):13630-40
references.pmid: 16227283
references.citation: J Natl Cancer Inst. 2000 May 3;92(9):690-8
references.pmid: 10793105
references.citation: Virology. 2010 Jun 20;402(1):197-202
references.pmid: 20394955
references.citation: Int J Cancer. 2011 Feb 15;128(4):927-35
references.pmid: 20473886
references.citation: N Engl J Med. 2003 Feb 6;348(6):518-27
references.pmid: 12571259
references.citation: J Microbiol Immunol Infect. 2004 Oct;37(5):282-7
references.pmid: 15497009
references.citation: Gynecol Oncol. 2004 Mar;92(3):873-80
references.pmid: 14984955
references.citation: J Gen Virol. 2004 Jun;85(Pt 6):1433-1444
references.pmid: 15166426
references.citation: Lancet. 2003 Jan 4;361(9351):40-3
references.pmid: 12517465
references.citation: Int J Cancer. 2002 Nov 20;102(3):237-43
references.pmid: 12397642
references.citation: Virology. 2011 Feb 5;410(1):64-75
references.pmid: 21093004
references.citation: J Korean Med Sci. 2005 Aug;20(4):636-42
references.pmid: 16100457
references.citation: Int J Cancer. 2002 Feb 20;97(6):868-74
references.pmid: 11857370
references.citation: J Natl Cancer Inst Monogr. 2003;(31):3-13
references.pmid: 12807939
references.citation: Int J Gynecol Cancer. 2005 Mar-Apr;15(2):312-8
references.pmid: 15823118
references.citation: Lancet. 2005 Sep 17-23;366(9490):991-8
references.pmid: 16168781
references.citation: Br J Cancer. 2009 Jul 7;101(1):202-8
references.pmid: 19536089
references.citation: J Clin Oncol. 2001 Apr 1;19(7):1906-15
references.pmid: 11283122
references.citation: J Med Virol. 2002 Aug;67(4):574-82
references.pmid: 12116007
references.citation: Nat Rev Cancer. 2002 May;2(5):342-50
references.pmid: 12044010
references.citation: J Biol Chem. 2005 Oct 28;280(43):36088-98
references.pmid: 16135518
references.citation: Cell Death Differ. 2008 Sep;15(9):1356-63
references.pmid: 18421300
references.citation: Oncol Rep. 2009 Feb;21(2):403-5
references.pmid: 19148514
references.citation: Virology. 2004 Feb 20;319(2):315-23
references.pmid: 14980491
references.citation: Clin Biochem. 2008 Apr;41(6):423-8
references.pmid: 18206116
references.citation: Braz J Microbiol. 2010 Jul;41(3):749-56
references.pmid: 24031552
references.citation: Gynecol Oncol. 2006 Feb;100(2):372-8
references.pmid: 16246404
references.citation: Br J Cancer. 2003 Jan 13;88(1):63-73
references.pmid: 12556961
references.citation: J Pathol. 2007 Aug;212(4):356-67
references.pmid: 17573670